rxstatShortages › Inosine Pranobex

Inosine Pranobex (Imunovir) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Inosine Pranobex has no current shortage reported in Canada. No active reports are on file.

An antiviral and immune-stimulating medication used to treat certain viral infections.

Products affected
0 / 1
Reports on file
1

Shortage history

2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

Resolved
IMUNOVIR
500MG · TABLET · KORA HEALTHCARE
DIN 02240713 · ended Jul 15, 2025

What's happening

There are no active shortage reports for Inosine Pranobex.

Inosine Pranobex is classified under “DIRECT ACTING ANTIVIRALS” (ATC J05AX).

Recent changes

Common questions

What is Inosine Pranobex used for?

An antiviral and immune-stimulating medication used to treat certain viral infections.

When will Inosine Pranobex be back in stock in Canada?

Inosine Pranobex has no active shortage; supply is normal per Health Canada reports.

Why is Inosine Pranobex in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (direct acting antivirals)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.